Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating zanubrutinib for adults with primary membranous nephropathy to assess its efficacy and safety; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Primary Membranous Nephropathy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING